Continuing Medical Education Programs
All programs are available free to the public.
Continuing Medical Education Programs
All programs are available free to the public.
Resources
For a complete list of continuing education programs, click here.
For programs in your area, visit your region website for a list of events.
To access patient education programs, click here.
Participate and earn CME credit:
Elevating Equity in Caring for Patients with Hematologic Malignancies
This activity is intended for hematology/oncology specialists, nurses and nurse practitioners, including those specializing in hematology/oncology.
Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults: Maximizing Transplant Eligibility
This activity is intended for hematologists/oncologists, nurses, nurse practitioners, and advanced practice nurses.
Supporting Our Colleagues: Easing the Burden of Referrals for CAR-T in Aggressive B-cell Lymphomas
This CE activity is intended for hematologic oncology clinicians who provide CAR-T therapy for individuals with aggressive B-cell lymphomas.
Identifying and Managing Complications of Acute Myeloid Leukemia in the Emergency Department
This CE activity is intended for physicians, physician assistants, nurse practitioners and nurses involved in the care of patients in the Emergency Department.
Updates in Treating Pediatric Leukemia
This CE activity is intended for oncologists, pediatric hematologist-oncologists, nurses, and oncology social workers involved in the care of patients with hematologic malignancies.
Opening the CAR(T) Door to Get Your Patients to Therapy
Part 4 of 4 in a series on: The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes
Avoiding Roadblocks in Coordinating CAR-T Therapy for B-cell Lymphoma: Practical Tips for Community Oncology Clinicians
Part 3 of 4 in a series on: The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes
The Road to Cures Through Immunotherapy and Precision Medicine
This activity provides learners with an overview of the latest advancements in biology and treatments for acute myeloid leukemia, aggressive lymphoma, and myeloma. The development and practical applications for CAR T-cell therapy in blood cancers is presented. A review of data from The Leukemia & Lymphoma Society patient registry on SARS-CoV-2 vaccination and antibody response in patients with blood cancer provides a glimpse of unmet needs in this vulnerable patient population.
What You MUST Know As More Lymphoma Patients Are On The Road To CAR-T
Part 2 of 4 in a series on: The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes
It's Time To Understand CAR-T Therapy For B-Cell Lymphoma: Earlier Indications Coming To A Community Near You
Part 1 of 4 in a series on: The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes